We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$4.47B
AUM Growth
+$651M
Cap. Flow
+$520M
Cap. Flow %
11.65%
Top 10 Hldgs %
45.49%
Holding
114
New
23
Increased
28
Reduced
17
Closed
41

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$239M
2
POST icon
Post Holdings
POST
+$178M
3
AVGO icon
Broadcom
AVGO
+$133M
4
AMH icon
American Homes 4 Rent
AMH
+$122M
5
DISH
DISH Network Corp.
DISH
+$104M

Top Sells

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$115M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$84.3M
3
VYX icon
NCR Voyix
VYX
+$82.1M
4
TCOM icon
Trip.com Group
TCOM
+$78.8M
5
BURL icon
Burlington
BURL
+$72.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.08%
2 Consumer Staples 10.63%
3 Healthcare 8.57%
4 Technology 8.37%
5 Communication Services 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTXS
101
CALL
DELISTED
Citrix Systems Inc
CTXS
– –
-879,060
Closed -$48.5M
ADXS
102
DELISTED
Advaxis Inc
ADXS
– –
-68,233
Closed -$10.5M
KSU
103
DELISTED
Kansas City Southern
KSU
– –
-405,000
Closed -$36.8M
NEOS
104
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-611,686
Closed -$12.9M
GNC
105
DELISTED
GNC Holdings, Inc.
GNC
– –
-1,168,940
Closed -$47.2M
DERM
106
DELISTED
Dermira, Inc.
DERM
– –
-103,213
Closed -$2.41M
AVP
107
PUT
DELISTED
Avon Products, Inc.
AVP
– –
-1,500,000
Closed -$4.88M
GNCA
108
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-87,361
Closed -$4.79M
HZNP
109
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-2,109,226
Closed -$41.8M
KATE
110
DELISTED
Kate Spade & Company
KATE
– –
-1,867,375
Closed -$36.5M
AVG
111
PUT
DELISTED
AVG Technologies N.V.
AVG
– –
-100,000
Closed -$2.17M
MW
112
CALL
DELISTED
THE MENS WAREHOUSE INC
MW
– –
-1,113,200
Closed -$47.3M
MW
113
DELISTED
THE MENS WAREHOUSE INC
MW
– –
-1,696,599
Closed -$72.1M
CIT
114
CALL
DELISTED
CIT Group Inc.
CIT
– –
-306,400
Closed -$12.3M
1 2 3 4
5

Similar funds

BC
Blueport Capital Fort Worth, Texas $5.8M AUM 4.95% 1-Year Est. Return
LBG
Lloyds Banking Group London, United Kingdom $7.15M AUM 0.75% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
ACM
Archer Capital Management New York $16.2M AUM 17.01% 1-Year Est. Return
MGFS
Miller Green Financial Services Spring, Texas $17.6M AUM
LA
Lexington Advisors New York $18.7M AUM 48.36% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
NMM
NGP MR Management Dallas, Texas $23.4M AUM 15.8% 1-Year Est. Return

Tourbillon Capital Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Tourbillon Capital Partners held 114 positions worth $4.47B, up 17% from $3.82B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Tourbillon Capital Partners deployed $520M of net new capital in Q4 2015, opening 23 new positions and adding to 28 existing holdings. Its largest new stake was Pfizer: 7,610,331 shares worth $233M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 24% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was Expedia Group, an estimated $115M trimmed.

  • Tourbillon Capital Partners's largest Q4 2015 buy was Pfizer: 7,610,331 shares worth $233M.
  • Tourbillon Capital Partners added most to Post Holdings in Q4 2015, an estimated $178M increase.
  • Tourbillon Capital Partners's biggest Q4 2015 reduction was Expedia Group, cutting an estimated $115M.
  • Tourbillon Capital Partners fully exited Teva Pharmaceuticals in Q4 2015, selling an estimated $84.3M.
  • Tourbillon Capital Partners's ten largest holdings make up 45% of its $4.47B portfolio in Q4 2015.
  • Tourbillon Capital Partners opened 23 new positions and closed 41 in Q4 2015.
  • Tourbillon Capital Partners's portfolio value rose 17% quarter-over-quarter to $4.47B.

Based on Tourbillon Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.